In the IMS stage of intense struggle between tumor cells and immune cells, PD-L1 expression was concentrated at the invasive margin of tumor cells and immune cells, where it fully binds to PD-1 and promotes the exhaustion of T cells. The gene discussed is CD274; the disease is neoplasm.